Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tuomas Mirtti

Showing results (101-110 of 125) with videos related to

Pageof 13
Sort By:
Molecular Oncology|December 3, 2022
PP2A methylesterase PME-1 suppresses anoikis and is associated with therapy relapse of PTEN-deficient prostate cancersAnna Aakula, Aleksi Isomursu, Christian Rupp, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 20, 2023
Visual Assessment of 2-Dimensional Levels Within 3-Dimensional Pathology Data Sets of Prostate Needle Biopsies Reveals Substantial Spatial HeterogeneityCan Koyuncu, Andrew Janowczyk, Xavier Farre, et al.
European Urology Open Science|July 11, 2022
Characteristics of Patients in SPCG-15-A Randomized Trial Comparing Radical Prostatectomy with Primary Radiotherapy plus Androgen Deprivation Therapy in Men with Locally Advanced Prostate CancerMagdalena Gongora, Johan Stranne, Eva Johansson, et al.
European Urology Oncology|May 8, 2026
PI-RADS v2 and Adverse Prostate Cancer Outcomes: A Cross-cohort Replication Study Across Three CentersTolou Shadbahr, Juho Pylväläinen, Juho Eineluoto, et al.
Oncoimmunology|September 14, 2020
Tumor microenvironment remodeling by an engineered oncolytic adenovirus results in improved outcome from PD-L1 inhibitionVictor Cervera-Carrascon, Dafne C A Quixabeira, Joao Manuel Santos, et al.
Communications Medicine|October 6, 2023
The impact of imputation quality on machine learning classifiers for datasets with missing valuesTolou Shadbahr, Michael Roberts, Jan Stanczuk, et al.
Cancer Research Communications|February 4, 2026
Functionally characterizing the renal cell carcinoma tumor immune microenvironment via patient-derived ex vivo modelsNeja Sirc, Johannes Smolander, Anita N Kumari, et al.
The American Journal of Surgical Pathology|October 7, 2017
Feasibility of Prostate PAXgene Fixation for Molecular Research and Diagnostic Surgical Pathology: Comparison of Matched Fresh Frozen, FFPE, and PFPE TissuesGunilla Högnäs, Kati Kivinummi, Heini M L Kallio, et al.
JAMA|April 6, 2024
Prostate Cancer Screening With PSA, Kallikrein Panel, and MRI: The ProScreen Randomized TrialAnssi Auvinen, Teuvo L J Tammela, Tuomas Mirtti, et al.
Communications Biology|October 19, 2024
Distinct molecular profiles and shared drug vulnerabilities in pancreatic metastases of renal cell carcinomaMatilda Roos-Mattila, Pauliina Kallio, Tamara J Luck, et al.
Pageof 13

Showing results (101-110 of 125) with videos related to

Sort By:
Pageof 13
Molecular Oncology|December 3, 2022
PP2A methylesterase PME-1 suppresses anoikis and is associated with therapy relapse of PTEN-deficient prostate cancersAnna Aakula, Aleksi Isomursu, Christian Rupp, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 20, 2023
Visual Assessment of 2-Dimensional Levels Within 3-Dimensional Pathology Data Sets of Prostate Needle Biopsies Reveals Substantial Spatial HeterogeneityCan Koyuncu, Andrew Janowczyk, Xavier Farre, et al.
European Urology Open Science|July 11, 2022
Characteristics of Patients in SPCG-15-A Randomized Trial Comparing Radical Prostatectomy with Primary Radiotherapy plus Androgen Deprivation Therapy in Men with Locally Advanced Prostate CancerMagdalena Gongora, Johan Stranne, Eva Johansson, et al.
European Urology Oncology|May 8, 2026
PI-RADS v2 and Adverse Prostate Cancer Outcomes: A Cross-cohort Replication Study Across Three CentersTolou Shadbahr, Juho Pylväläinen, Juho Eineluoto, et al.
Oncoimmunology|September 14, 2020
Tumor microenvironment remodeling by an engineered oncolytic adenovirus results in improved outcome from PD-L1 inhibitionVictor Cervera-Carrascon, Dafne C A Quixabeira, Joao Manuel Santos, et al.
Communications Medicine|October 6, 2023
The impact of imputation quality on machine learning classifiers for datasets with missing valuesTolou Shadbahr, Michael Roberts, Jan Stanczuk, et al.
Cancer Research Communications|February 4, 2026
Functionally characterizing the renal cell carcinoma tumor immune microenvironment via patient-derived ex vivo modelsNeja Sirc, Johannes Smolander, Anita N Kumari, et al.
The American Journal of Surgical Pathology|October 7, 2017
Feasibility of Prostate PAXgene Fixation for Molecular Research and Diagnostic Surgical Pathology: Comparison of Matched Fresh Frozen, FFPE, and PFPE TissuesGunilla Högnäs, Kati Kivinummi, Heini M L Kallio, et al.
JAMA|April 6, 2024
Prostate Cancer Screening With PSA, Kallikrein Panel, and MRI: The ProScreen Randomized TrialAnssi Auvinen, Teuvo L J Tammela, Tuomas Mirtti, et al.
Communications Biology|October 19, 2024
Distinct molecular profiles and shared drug vulnerabilities in pancreatic metastases of renal cell carcinomaMatilda Roos-Mattila, Pauliina Kallio, Tamara J Luck, et al.
Pageof 13